Skip to content

Effect of Fu's Subcutaneous Needling on functional magnetic resonance imaging of lbp patients

Effect of Fu's Subcutaneous Needling on functional magnetic resonance imaging of lbp patients

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005348
Enrollment
Unknown
Registered
2021-11-28
Start date
2021-11-25
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-specific low back pain

Interventions

Observation group:Fu's Subcutaneous Needling

Sponsors

Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for nonspecific low back pain: (1) right handedness; (2) there is pain and discomfort in the back and / or lumbosacral part, which shall be determined according to the clinical evaluation of clinical symptoms, including X-ray or MRI examination report (if any); (3) age 18-60 years; (4) one week before screening, visual analogue scale of pain (VAS) = 4 points; (5) did not take sleeping and analgesic drugs within 1 week before participating in the study; (6) those rated as normal by self rating Anxiety Scale (SAS) and self rating Depression Scale (SDS); (7) sign the informed consent form and agree to participate in the study.

Exclusion criteria

Exclusion criteria: (1) low back pain caused by cancer, fracture, spinal stenosis, infection, etc; (2) have a history of other chronic pain and mental illness; ? history of spinal surgery, trauma, etc. (4) there are other MRI contraindications, such as cardiac pacemaker, metal implant, fear of confined space, pregnancy, etc. (5) inferior genicular nerve root pain. (6) history of heart, respiratory or nervous system diseases. According to the judgment of the researcher, MRI examination may cause adverse events or potential harm to the patient, so it is unable to participate in the study. For example, asthma or claustrophobia.

Design outcomes

Primary

MeasureTime frame
fMRI;

Countries

China

Contacts

Public Contactbaitianyu
baitinayu19820217@163.com15168869181

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026